Mark Olfson1, Steven C Marcus. 1. Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York, 10032, USA. mo49@columbia.edu
Abstract
OBJECTIVE: The authors investigated recent trends in the use of outpatient psychotherapy in the United States. METHOD: Service use data from two representative surveys of the U.S. general population, the 1998 (N=22,953) and 2007 (N=29,370) Medical Expenditure Panel Surveys, were analyzed, focusing on individuals who made more than one outpatient psychotherapy visit during that calendar year. The authors computed rates of any psychotherapy use; percentages of persons treated for mental health conditions with only psychotherapy, only psychotropic medication, or their combination; the mean number of psychotherapy visits of persons receiving psychotherapy; and psychotherapy expenditures. RESULTS: The percentage of persons using outpatient psychotherapy was 3.37% in 1998 and 3.18% in 2007 (adjusted odds ratio=0.95, 95% CI=0.82-1.09). Among individuals receiving outpatient mental health care, use of only psychotherapy (15.9% and 10.5% in 1998 and 2007, respectively; adjusted odds ratio=0.66, 95% CI=0.48-0.90) as well as psychotherapy and psychotropic medication together (40.0% and 32.1%; adjusted odds ratio=0.73, 95% CI=0.59-0.90) declined while use of only psychotropic medication increased (44.1% and 57.4%; adjusted odds ratio=1.63, 95% CI=1.32-2.00). Declines occurred in annual psychotherapy visits per psychotherapy patient (mean values, 9.7 and 7.9; adjusted β=-1.53, p<0.0001), mean expenditure per psychotherapy visit ($122.80 and $94.59; β=28.21, p<0.0001), and total national psychotherapy expenditures ($10.94 and $7.17 billion; z=2.61, p=0.009). CONCLUSIONS: During the decade from 1998 to 2007, the percentage of the general population who used psychotherapy remained stable. Over the same period, however, psychotherapy assumed a less prominent role in outpatient mental health care as a large and increasing proportion of mental health outpatients received psychotropic medication without psychotherapy.
OBJECTIVE: The authors investigated recent trends in the use of outpatient psychotherapy in the United States. METHOD: Service use data from two representative surveys of the U.S. general population, the 1998 (N=22,953) and 2007 (N=29,370) Medical Expenditure Panel Surveys, were analyzed, focusing on individuals who made more than one outpatient psychotherapy visit during that calendar year. The authors computed rates of any psychotherapy use; percentages of persons treated for mental health conditions with only psychotherapy, only psychotropic medication, or their combination; the mean number of psychotherapy visits of persons receiving psychotherapy; and psychotherapy expenditures. RESULTS: The percentage of persons using outpatient psychotherapy was 3.37% in 1998 and 3.18% in 2007 (adjusted odds ratio=0.95, 95% CI=0.82-1.09). Among individuals receiving outpatient mental health care, use of only psychotherapy (15.9% and 10.5% in 1998 and 2007, respectively; adjusted odds ratio=0.66, 95% CI=0.48-0.90) as well as psychotherapy and psychotropic medication together (40.0% and 32.1%; adjusted odds ratio=0.73, 95% CI=0.59-0.90) declined while use of only psychotropic medication increased (44.1% and 57.4%; adjusted odds ratio=1.63, 95% CI=1.32-2.00). Declines occurred in annual psychotherapy visits per psychotherapy patient (mean values, 9.7 and 7.9; adjusted β=-1.53, p<0.0001), mean expenditure per psychotherapy visit ($122.80 and $94.59; β=28.21, p<0.0001), and total national psychotherapy expenditures ($10.94 and $7.17 billion; z=2.61, p=0.009). CONCLUSIONS: During the decade from 1998 to 2007, the percentage of the general population who used psychotherapy remained stable. Over the same period, however, psychotherapy assumed a less prominent role in outpatient mental health care as a large and increasing proportion of mental health outpatients received psychotropic medication without psychotherapy.
Authors: Dina Vivian; Rachel Hershenberg; Bethany A Teachman; Deborah A G Drabick; Marvin R Goldfried; Barry Wolfe Journal: Psychotherapy (Chic) Date: 2012-06
Authors: Greta A Bushnell; Stacie B Dusetzina; Scott N Compton; Bradley N Gaynes; M Alan Brookhart; Til Stürmer Journal: J Child Adolesc Psychopharmacol Date: 2018-12-19 Impact factor: 2.576
Authors: Geetha Shivakumar; Anna R Brandon; Peter G Snell; Patricia Santiago-Muñoz; Neysa L Johnson; Madhukar H Trivedi; Marlene P Freeman Journal: Depress Anxiety Date: 2010-12-13 Impact factor: 6.505
Authors: Benjamin Lê Cook; Michael Flores; Samuel H Zuvekas; Joseph P Newhouse; John Hsu; Rajan Sonik; Esther Lee; Vicki Fung Journal: Health Aff (Millwood) Date: 2020-05 Impact factor: 6.301
Authors: Sapana R Patel; Jennifer L Humensky; Mark Olfson; Helen Blair Simpson; Robert Myers; Lisa B Dixon Journal: Psychiatr Serv Date: 2014-05-01 Impact factor: 3.084
Authors: Sascha Abbas; Peter Ihle; Jürgen-Bernhard Adler; Susanne Engel; Christian Günster; Martin Holtmann; Axel Kortevoss; Roland Linder; Werner Maier; Gerd Lehmkuhl; Ingrid Schubert Journal: Eur Child Adolesc Psychiatry Date: 2016-09-14 Impact factor: 4.785